Cargando…

Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma

OBJECTIVE: To investigate the expression of programmed death ligand-1 (PD-L1) and the levels of CD8(+) tumor-infiltrating lymphocytes (TILs) in meningioma as well as determine the association between their levels and the clinical outcomes. METHODS: We performed a retrospective case-control study on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yaochuan, Wang, Xiaoliang, Shi, Mengwu, Song, Yifu, Yu, Juanhan, Han, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655806/ https://www.ncbi.nlm.nih.gov/pubmed/36371159 http://dx.doi.org/10.1186/s12885-022-10249-4

Ejemplares similares

PD-L1 and tumor-infiltrating CD8(+) lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas
por: Shi, Mengwu, et al.
Publicado: (2023)

Decreased CD8(+) Lymphocytic Infiltration in Multifocal and Multicentric Glioblastomas
por: Wang, Run, et al.
Publicado: (2021)

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer
por: Baretti, Marina, et al.
Publicado: (2022)

Metastasis of pulmonary adenocarcinoma to right occipital parafalcine meningioma: A case report and literature review
por: Hu, Tianhao, et al.
Publicado: (2020)

Detection of programmed death ligand 1 protein and CD8(+) lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures
por: Wang, Pengfei, et al.
Publicado: (2017)

Expression of programmed death-ligand 1, IRF1 and CD8 T lymphocyte infiltration in a primary subset of breast cancer patients in Sudan
por: Salih, Shahenaz S., et al.
Publicado: (2023)

Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
por: Chang, Hyeyoon, et al.
Publicado: (2016)

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma
por: Zhu, Jun, et al.
Publicado: (2017)

Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8(+) lymphocytes in primary sarcomas is subtype dependent
por: van Erp, Anke E.M., et al.
Publicado: (2017)

CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression
por: Nagano, Mayuko, et al.
Publicado: (2021)

Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
por: El Samman, Dina Mohamed, et al.
Publicado: (2021)

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
por: Luo, Fan, et al.
Publicado: (2021)

Correction to: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes
por: Luo, Fan, et al.
Publicado: (2022)

Programmed death ligand‐1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder
por: Wang, Bo, et al.
Publicado: (2018)

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
por: Feng, Yong, et al.
Publicado: (2015)

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer
por: Bae, Sang Byung, et al.
Publicado: (2016)

Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients
por: Zhao, Yu-Jie, et al.
Publicado: (2017)

Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis
por: Zhang, Lijian, et al.
Publicado: (2022)

Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer
por: Shen, Tao, et al.
Publicado: (2017)

Immunohistochemical Expression of Programmed Death Ligand-1 (PDL-1) in Colorectal carcinoma and Its Correlation with Stromal Tumor Infiltrating Lymphocytes
por: ELfishawy, Mona, et al.
Publicado: (2020)

Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
por: Garg, Gaurav, et al.
Publicado: (2021)

Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer
por: Sangkhamanon, Sakkarn, et al.
Publicado: (2023)

Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8(+) T Cells in Non-Small Cell Lung Cancer
por: Li, Yi-Ming, et al.
Publicado: (2019)

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014)

The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma
por: Zhang, Chaoting, et al.
Publicado: (2019)

Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu
por: Maskey, Ninu, et al.
Publicado: (2019)

Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
por: Yazaki, Shu, et al.
Publicado: (2022)

Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
por: Huang, Chih-Yang, et al.
Publicado: (2018)

Reactive glia promote development of CD103(+)CD69(+) CD8(+) T‐cells through programmed cell death‐ligand 1 (PD‐L1)
por: Prasad, Sujata, et al.
Publicado: (2018)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
por: Cui, Shaohua, et al.
Publicado: (2018)

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2017)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020)

The Expression of Programmed Death-1 on CD4(+) and CD8(+) T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis
por: Jia, Yumei, et al.
Publicado: (2016)

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
por: Rathore, Ankita Singh, et al.
Publicado: (2014)

Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
por: Lee, Jieun, et al.
Publicado: (2019)

Evaluation of the Role of Tumor-Infiltrating Lymphocytes and CD8(+) Cytotoxic Lymphocytes in the Survival of Patients with Breast Cancer
por: Shojaei, Shahram, et al.
Publicado: (2023)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy
por: Yu, Alice, et al.
Publicado: (2018)

Clinical relevance and significance of programmed death-ligand 1 expression, tumor-infiltrating lymphocytes, and p16 status in sinonasal squamous cell carcinoma
por: Quan, Huatao, et al.
Publicado: (2019)

CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes
por: Jiménez-Fernández, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gpak89ruk8p2u67c27ffoo382